These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 39103751)

  • 121. Clinical features and prognosis of patients with myeloid neoplasms harboring t(7;11)(p15;p15) translocation: a single-center retrospective study.
    Liu L; Zhao S; Wang L; Xu H; Chen Z; Tu J; Huang J; Jin J; Tong H
    BMC Cancer; 2024 Aug; 24(1):955. PubMed ID: 39103751
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocation.
    Wei S; Wang S; Qiu S; Qi J; Mi Y; Lin D; Zhou C; Liu B; Li W; Wang Y; Wang M; Wang J
    Leuk Res; 2013 Sep; 37(9):1010-5. PubMed ID: 23800796
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Molecular heterogeneity of the NUP98/HOXA9 fusion transcript in myelodysplastic syndromes associated with t(7;11)(p15;p15).
    Hatano Y; Miura I; Nakamura T; Yamazaki Y; Takahashi N; Miura AB
    Br J Haematol; 1999 Dec; 107(3):600-4. PubMed ID: 10583265
    [TBL] [Abstract][Full Text] [Related]  

  • 124. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG).
    Jaju RJ; Haas OA; Neat M; Harbott J; Saha V; Boultwood J; Brown JM; Pirc-Danoewinata H; Krings BW; Müller U; Morris SW; Wainscoat JS; Kearney L
    Blood; 1999 Jul; 94(2):773-80. PubMed ID: 10397745
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Low frequency of rearrangements of the homeobox gene HOXA9/t(7;11) in adult acute myeloid leukemia.
    Kwong YL; Pang A
    Genes Chromosomes Cancer; 1999 May; 25(1):70-4. PubMed ID: 10221343
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Precision and strategic targeting of novel mutation-specific vulnerabilities in acute myeloid leukemia: the semi-centennial of 7 + 3.
    Patel SA
    Leuk Lymphoma; 2023 Sep; 64(9):1503-1513. PubMed ID: 37328939
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling.
    Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L
    Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Silencing with SAFB: a new role for HOXA9 in AML.
    Deshpande AJ; Zhu N
    Blood; 2023 Apr; 141(14):1653-1655. PubMed ID: 37022737
    [No Abstract]   [Full Text] [Related]  

  • 129. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.
    Issa GC; Aldoss I; DiPersio J; Cuglievan B; Stone R; Arellano M; Thirman MJ; Patel MR; Dickens DS; Shenoy S; Shukla N; Kantarjian H; Armstrong SA; Perner F; Perry JA; Rosen G; Bagley RG; Meyers ML; Ordentlich P; Gu Y; Kumar V; Smith S; McGeehan GM; Stein EM
    Nature; 2023 Mar; 615(7954):920-924. PubMed ID: 36922593
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group.
    Cantu MD; Kanagal-Shamanna R; Wang SA; Kadia T; Bueso-Ramos CE; Patel SS; Geyer JT; Tam W; Madanat Y; Li P; George TI; Nichols MM; Rogers HJ; Liu YC; Aggarwal N; Kurzer JH; Maracaja DLV; Hsi ED; Zaiem F; Babu D; Foucar K; Laczko D; Bagg A; Orazi A; Arber DA; Hasserjian RP; Weinberg OK
    JCO Precis Oncol; 2023 Jan; 7():e2200400. PubMed ID: 36689697
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of
    Abbas HA; Ayoub E; Sun H; Kanagal-Shamanna R; Short NJ; Issa G; Yilmaz M; Pierce S; Rivera D; Cham B; Wing S; Li Z; Hammond D; Jabbour E; Borthakur G; Garcia-Manero G; Andreeff M; Daver N; Kadia T; Konopleva M; DiNardo C; Ravandi F
    Leuk Lymphoma; 2022 Dec; 63(13):3105-3116. PubMed ID: 36089905
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
    Döhner H; Wei AH; Appelbaum FR; Craddock C; DiNardo CD; Dombret H; Ebert BL; Fenaux P; Godley LA; Hasserjian RP; Larson RA; Levine RL; Miyazaki Y; Niederwieser D; Ossenkoppele G; Röllig C; Sierra J; Stein EM; Tallman MS; Tien HF; Wang J; Wierzbowska A; Löwenberg B
    Blood; 2022 Sep; 140(12):1345-1377. PubMed ID: 35797463
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Frequency of FLT3 Internal Tandem Duplications in Adult Syrian Patients with Acute Myeloid Leukemia and Normal Karyotype.
    Al-Arbeed IF; Wafa A; Moassass F; Al-Halabi B; Al-Achkar W; Abou-Khamis I
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3245-3251. PubMed ID: 34711001
    [TBL] [Abstract][Full Text] [Related]  

  • 134. The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML.
    Heikamp EB; Henrich JA; Perner F; Wong EM; Hatton C; Wen Y; Barwe SP; Gopalakrishnapillai A; Xu H; Uckelmann HJ; Takao S; Kazansky Y; Pikman Y; McGeehan GM; Kolb EA; Kentsis A; Armstrong SA
    Blood; 2022 Feb; 139(6):894-906. PubMed ID: 34582559
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Re: International System for Human Cytogenetic or Cytogenomic Nomenclature (ISCN): Some Thoughts, by T. Liehr.
    McGowan-Jordan J; Hastings R; Moore S
    Cytogenet Genome Res; 2021; 161(5):225-226. PubMed ID: 34407535
    [No Abstract]   [Full Text] [Related]  

  • 136. JMJD3-regulated expression of IL-6 is involved in the proliferation and chemosensitivity of acute myeloid leukemia cells.
    Xu X; Ye Y; Wang X; Lu B; Guo Z; Wu S
    Biol Chem; 2021 Jun; 402(7):815-824. PubMed ID: 33742970
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.
    Michmerhuizen NL; Klco JM; Mullighan CG
    Blood; 2020 Nov; 136(20):2275-2289. PubMed ID: 32766874
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Homogeneously staining region (hsr) on chromosome 11 is highly specific for KMT2A amplification in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    Sakhdari A; Tang Z; Ok CY; Bueso-Ramos CE; Medeiros LJ; Huh YO
    Cancer Genet; 2019 Oct; 238():18-22. PubMed ID: 31425921
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.
    Hartmann L; Haferlach C; Meggendorfer M; Kern W; Haferlach T; Stengel A
    Genes Chromosomes Cancer; 2019 Oct; 58(10):698-704. PubMed ID: 30994218
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance.
    Stevens AM; Miller JM; Munoz JO; Gaikwad AS; Redell MS
    Blood Adv; 2017 Aug; 1(18):1387-1397. PubMed ID: 29296780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.